Molecular Biology Reports

, Volume 26, Issue 3, pp 173–177 | Cite as

Interaction between Wiskott–Aldrich Syndrome Protein (WASP) and the Fyn protein-tyrosine kinase

  • Sharon Banin
  • Ivan Gout
  • Paul Brickell
Article

Abstract

Wiskott-Aldrich Syndrome (WAS) is a severe X-linked disorder characterised by immune deficiency, thrombocytopenia and eczema, resulting from abnormalities in a range of haematopoietic cell types. The protein that is defective in WAS, named WASP, appears to be involved in regulating changes in the cytoskeletal organisation of haematopoietic cells in response to external stimuli. In support of this idea, WASP has been found to be physically associated in haematopoietic cells in vivo with a number of SH3 domain-containing proteins involved in signal transduction, including the cytoplasmic protein-tyrosine kinase Fyn. Here, we have used a baculovirus expression system to explore the biochemical consequences of the interaction between WASP and Fyn. We find that the kinase activity of Fyn is stimulated as a result of binding to WASP, and that a cellular protein, which may be WASP itself, becomes phosphorylated on tyrosine as a result of the binding of WASP to Fyn.

Fyn phosphorylation protein-tyrosine kinase WASP Wiskott-Aldrich Syndrome 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Remold-O'Donnell E, Rosen FS & Kenney DM (1996) Blood 87: 2621–2631.PubMedGoogle Scholar
  2. 2.
    Brickell PM, Katz DR & Thrasher AJ (1998) Br. J. Haematol. 101: 603–608.PubMedGoogle Scholar
  3. 3.
    Gallego MD, Santamaria M, Pena J & Molina IJ (1997) Blood 90: 3089–3097.PubMedGoogle Scholar
  4. 4.
    Zicha D, Allen WE, Brickell PM, Kinnon C, Dunn GA, Jones GE & Thrasher AJ (1998) Br. J. Haematol. 101: 659–665.PubMedGoogle Scholar
  5. 5.
    Badolato R, Sozzani S, Malacarne F, Bresciani S, Fiorini M, Borsatti A, Albertini A, Mantovani A, Ugazio AG & Notarangelo LD (1998) J. Immunol. 161: 1026–1033.PubMedGoogle Scholar
  6. 6.
    Binks M, Jones GE, Brickell PM, Kinnon C, Katz DR & Thrasher AJ (1998) Eur. J. Immunol. 28: 3259–3267.PubMedGoogle Scholar
  7. 7.
    Semple JW, Siminovitch KA, Mody M, Milev Y, Lazarus AH, Wright JF, Freedman J (1997) Br. J. Haematol. 97: 747–754.PubMedGoogle Scholar
  8. 8.
    Derry JMJ, Ochs HJ & Francke U (1994) Cell 78: 635–644.PubMedGoogle Scholar
  9. 9.
    Symons M, Derry JMJ, Kariak B, Jiang S, Lemahieu V, McCormick F, Francke U & Abo A (1996) Cell 84: 723–734.PubMedGoogle Scholar
  10. 10.
    Aspenström P, Lindberg U & Hall A (1996) Curr. Biol. 6: 70–75.PubMedGoogle Scholar
  11. 11.
    Rivero-Lezcano OM, Marcilla A, Sameshima JH & Robbins KC (1995) Mol. Cell. Biol. 15: 5725–5731.PubMedGoogle Scholar
  12. 12.
    Miki H, Nonyama S, Zhu Q, Aruffo A, Ochs HD & Takenawa T (1997) Cell Growth Differ. 8: 195–202.PubMedGoogle Scholar
  13. 13.
    She HY, Rockow S, Tang J, Nishimura R, Skolnik EY, Chen M, Margolis B, Li W (1997) Mol. Biol. Cell 8: 1709–1721.PubMedGoogle Scholar
  14. 14.
    Wu Y, Dowbenko D, Lasky LA (1998) J. Biol. Chem. 273: 30487–30496.PubMedGoogle Scholar
  15. 15.
    Banin S, Truong O, Katz DR, Waterfield MD, Brickell PM & Gout I (1996) Curr. Biol. 6: 981–988.PubMedGoogle Scholar
  16. 16.
    Pleiman CM, D'Ambrosio D & Cambier JC (1994) Immunol. Today 15: 393–399.PubMedGoogle Scholar
  17. 17.
    Chan AC, Desai DM & Weiss A (1994) Ann. Rev. Immunol. 12: 555–592.Google Scholar
  18. 18.
    Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, Bartke I, Knapp W & Stockinger H (1995) J. Exp. Med. 181: 1381–1390.PubMedGoogle Scholar
  19. 19.
    Cory GOC, MacCarthy-Morrogh L, Banin S, Gout I, Brickell P, Levinsky RJ, Kinnon C & Lovering RC (1996) J. Immunol. 157: 3791–3795.PubMedGoogle Scholar
  20. 20.
    Finan PM, Soames CJ, Wilson L, Nelson DL, Stewart DM, Truong O, Hsuan JJ & Kellie S (1996) J. Biol. Chem. 271, 26291–26295.PubMedGoogle Scholar
  21. 21.
    Xu W, Harrison SC & Eck MJ (1997) Nature 385: 595–602.PubMedGoogle Scholar
  22. 22.
    Sicheri F, Moarefi I & Kuriyan J (1997) Nature 385: 602–609.PubMedGoogle Scholar
  23. 23.
    Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J & Miller WT (1997) Nature 385: 650–653.PubMedGoogle Scholar
  24. 24.
    Pawson T (1997) Nature 385: 582–583.PubMedGoogle Scholar
  25. 25.
    Gout I, Dhand R, Hiles ID, Fry MJ, Panayotou G, Das P, Truong O, Totty NF, Hsuan J, Booker GW, Campbell ID & Waterfield MD (1993) Cell 7: 25–36.Google Scholar
  26. 26.
    Koegl M, Kypta RM, Bergman M, Alitalo K & Courtneidge SA (1994) Biochem. J. 302: 737–744.PubMedGoogle Scholar
  27. 27.
    Guinamard R, Aspenström P, Fougereau M, Chavrier P, Guillemot JC (1998) FEBS Lett. 434: 431–436.PubMedGoogle Scholar
  28. 28.
    Oda A, Ochs HD, Druker BJ, Ozaki K, Watanabe C, Handa M, Miyakawa Y, Ikeda Y (1998) Blood 92: 1852–1858.PubMedGoogle Scholar
  29. 29.
    Schmitz R, Baumann G & Gram H (1996) J. Mol. Biol. 260: 664–677.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Sharon Banin
    • 1
  • Ivan Gout
    • 2
  • Paul Brickell
    • 1
  1. 1.Leukaemia Research Fund Centre for Childhood Leukaemia, Molecular Haematology UnitInstitute of Child HealthLondonUK
  2. 2.Ludwig Institute for Cancer ResearchUniversity College London Medical SchoolLondonUK

Personalised recommendations